Conference
976P Efficacy of immune checkpoint inhibitors (ICI) and genomic alterations by body mass index (BMI) in advanced renal cell carcinoma (RCC)
Abstract
Background An elevated BMI is associated with improved prognosis in certain solid tumors treated with ICI; however, real-world data and genomic analysis has been lacking. We investigated the effect of BMI on RCC patients treated with PD-1/PD-L1 based ICI and explored potential genomic alterations (GA). Methods Using the International Metastatic RCC Database Consortium (IMDC) database, we performed a retrospective analysis on patients treated …
Authors
Lalani A-KA; Bakouny Z; Farah S; Xie W; Flippot R; Steinharter JA; Nuzzo PV; Fleischer J; Pal SK; Rathi N
Volume
30
Publisher
Elsevier
Publication Date
October 2019
DOI
10.1093/annonc/mdz249.072
Conference proceedings
Annals of Oncology
ISSN
0923-7534